LDHA/PDKs-IN-2
Product Specifications
UNSPSC Description
LDHA/PDKs-IN-2 (compound 20k) is a potent and dual inhibitor of PDKs and LDHA with IC50s of 1.6 and 0.7 μM, respectively. LDHA/PDKs-IN-2 reduces A549 cell proliferation with an EC50 of 15.7 μM and decreases the lactate formation, and increases oxygen consumption. LDHA/PDKs-IN-2 has the potential for the research of cancer diseases[1].
Target Antigen
PDK-1
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ldha-pdks-in-2.html
Solubility
10 mM in DMSO
Smiles
CC1=C(C(C=CO1)=O)OCCN2CCN(CC2)C(C3=CC=CO3)=O
Molecular Weight
332.35
References & Citations
[1]Xiang S, et al. Development of dual inhibitors targeting pyruvate dehydrogenase kinases and human lactate dehydrogenase A: High-throughput virtual screening, synthesis and biological validation. Eur J Med Chem. 2020;203:112579.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-146978/LDHA-PDKs-IN-2-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-146978/
Clinical Information
No Development Reported
CAS Number
2490699-44-8
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
OR1004015-01 50 mg
Tert-Butyl 4-[ (2R) -2- (Methoxycarbonyl) -4-oxo-1,3-oxazolidin-3-yl]piperidine-1-carboxylate
Ask
View Details